COMMUNIQUÉS West-GlobeNewswire

Paratek Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Remains on Track for Commercial Launch by First Quarter 2019
01/03/2018
Completed submission of NDAs for oral and intravenous omadacycline for the treatment of pneumonia and skin infections Expanded medical affairs and payer account management teams in readiness for discussions with [...]
Cannabis Wheaton Income Corp. and Sundial Sign Definitive Agreement for $7,000,000 in Debt Financing
01/03/2018
VANCOUVER, British Columbia, March 01, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX-V: CBW ) ( "Cannabis Wheaton" or the " Company ") is pleased to announce that it has entered into a definitive agreement [...]
News Release: Proposed combination between Essilor and Luxottica approved without conditions by the European Commission
01/03/2018
Proposed combination between Essilor and Luxottica approved without conditions by the European Commission PDF Version of the news release Charenton-le-Pont, France and Milan, Italy ( March 1, 2018 ) - Essilor (Euronext [...]
Communiqué : La Commission Européenne autorise sans condition le projet de rapprochement entre Essilor et Luxottica
01/03/2018
La Commission Européenne autorise sans condition le projet de rapprochement entre Essilor et Luxottica Version PDF du communiqué Charenton-le-Pont, France et Milan, Italie (le 1 er mars 2018) - Essilor (Euronext Paris [...]
Loxo Oncology Reports Fourth Quarter and Year-End 2017 Financial Results
01/03/2018
– Larotrectinib Rolling NDA Submission on Track for Completion in March – – LOXO-292 Phase 1 Clinical Data Update Expected in First Half 2018 – STAMFORD, Conn., March 01, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. ( [...]
Edge Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
01/03/2018
Interim Analysis from EG-1962 Phase 3 NEWTON 2 Study in Aneurysmal Subarachnoid Hemorrhage Expected by the End of April 2018 Full Top-Line Data from NEWTON 2 Study Expected in Late 2018 BERKELEY HEIGHTS, N.J., March 01 [...]
Wright Medical Group N.V. to Present at Barclays Global Healthcare Conference
01/03/2018
AMSTERDAM, The Netherlands, March 01, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI ) announced today that it will present at Barclays Global Healthcare Conference on Thursday, March 15, 2018, at the [...]
PotNetwork Holding Inc. Generates Over $3,000,000 in Sales Over First 45 days of 2018
01/03/2018
FT LAUDERDALE, Fla., March 01, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holding, Inc. (OTC Pink:POTN) (“Company”) announced today that its wholly owned subsidiary, Diamond CBD, Inc., just one and a half [...]
Shire plc : Total voting rights
01/03/2018
Total Voting Rights March 1, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") Disclosure Guidance and Transparency Rules, notifies the [...]
BIOPHYTIS updates on SARA clinical study of Sarconeos in sarcopenia and presents four posters at the International Conference on Frailty & Sarcopenia Research (ICFSR) in Miami
01/03/2018
Additional data confirm the relevance of the protocol and the compound in the clinical study SARA-INT phase 2B PARIS, March 01, 2018 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris:ALBPS) , a biotechnology company [...]
iCAD Granted CE Mark Approval in Europe for PowerLook Tomo Detection 2.0 Artificial Intelligence Solution
01/03/2018
Company’s Innovative Breast Cancer Detection Product is Compatible with Hologic, GE and Siemens Digital Breast Tomosynthesis Systems Significantly Expanding iCAD’s Global Market Opportunity VIENNA, Austria, March 01, [...]
Basilea names Adesh Kaul as new member of its Management Committee
01/03/2018
Basel, Switzerland, March 01, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that Adesh Kaul will join Basilea's Management Committee as Chief Corporate Development Officer effective March 01, 2018. He [...]
Novartis and Pear Therapeutics to develop digital therapeutics for patients with schizophrenia and multiple sclerosis
01/03/2018
Novartis and Pear Therapeutics to collaborate on prescription software applications aimed to treat patients with schizophrenia and multiple sclerosis Collaboration combines Novartis' leadership in biomedical research [...]
Biocartis Group NV: BIOCARTIS ANNOUNCES 2017 RESULTS AND 2018 OUTLOOK
01/03/2018
PRESS RELEASE: REGULATED INFORMATION Thursday, 1 March 2018, 07:02 CET BIOCARTIS ANNOUNCES 2017 RESULTS AND 2018 OUTLOOK Mechelen, Belgium , 1 March 2018 - Biocartis Group NV (the 'Company' or 'Biocartis'), an [...]
Biocartis Group NV: Biocartis Establishes R&D Center in the US
01/03/2018
PRESS RELEASE : 1 March 2018, 07:01 CET Biocartis Establishes R&D Center in the US Biocartis team strengthened with joining of Janssen Diagnostic's Idylla(TM) assay development team Mechelen, Belgium, 1 March 2018 [...]
argenx reports fourth quarter business update and full year 2017 financial results
01/03/2018
Management to host conference call today at 3 pm CET / 9 am EST March 1, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep [...]
Biocartis Group NV: European Union provides Biocartis with up to EUR 24m debt financing facility for infectious disease projects
01/03/2018
PRESS RELEASE : REGULATED INFORMATION - INSIDE INFORMATION 1 March 2018, 07:00 CET European Union provides Biocartis with up to EUR 24m debt financing facility for infectious disease projects Mechelen, Belgium, 1 March [...]
Targovax ASA: Issuance of restricted stock unites (RSUs) to the chairman of the board of directors
01/03/2018
Reference is made to the extraordinary general meeting of Targovax ASA (the "Company") on 30 November 2017, where Patrick Vink was elected as chairman of the Company's board of directors and the Company was authorized [...]
Essilor News Release: Solid 2017 earnings Strong fourth quarter
01/03/2018
Solid 2017 earnings Strong fourth quarter PDF Version of the news release Revenue: Up 6.7% at constant exchange rates, up 3.1% like-for-like Robust growth in the United States and e-commerce activities Adjusted [...]

Pages